The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs

International Journal of Pharmaceutics

Volumn 284, Issue 1-2, 2004, Pages 109-122

  Kipp, J E ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Clofazimine; Drug delivery; Homogenization; Itraconazole; Milling; Nanosuspension; Parenteral; Precipitation; Solubility; Stability

Indexed keywords

APREPITANT; BENZATHINE PENICILLIN; BUPIVACAINE; CLOFAZIMINE; DANAZOL; DEXAMETHASONE; DEXAMETHASONE ACETATE; DISSOCUBES; FLURBIPROFEN; HUMAN INSULIN; HYDROXYITRACONAZOLE; INSULIN; INSULIN ZINC SUSPENSION; ITRACONAZOLE; LENTE; LIPOSOME; METHYLPREDNISOLONE ACETATE; NANOPARTICLE; NAPROXEN; POLYSTYRENE; RAPAMYCIN; SPORANOX IV; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG SOLUBILITY; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INFUSIONS, PARENTERAL; NANOSTRUCTURES; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; WATER;

EID: 5344234787     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.07.019     Document Type: Review

References (76)

1. R.M. Abra, and C.A. Hunt Liposome disposition in vivo. 3. Dose and vesicle effects Biochim. Biophys. Acta 666 1981 493 503
2. A.J. Aguiar, J. Krc, A.W. Kinkel, and J.C. Samyn Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate J. Pharm. Sci. 56 1967 847 853
3. A.J. Aguiar, and J.E. Zelmer Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid J. Pharm. Sci. 58 1969 983 987
4. AHFS Drug Information, 1997. American Hospital Formulary Service. Bethesda, MD, pp. 1374-1378.
5. P. Alexandridis, and T.A. Hatton Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling (review) Colloids Surf. A: Physicochem. Eng. Aspects 96 1995 1 46
6. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Yong Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
7. F.A. Alvarez-Nunez, and S.H. Yalkowsky Buffer capacity and precipitation control of pH solubilized phenytoin formulations Int. J. Pharm. 185 1999 45 49
8. D. Andes In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis Antimicrob. Agents Chemother. 2003 1179 1186
9. M.F. Ashby, and D.R.-H. Jones Engineering Materials. 1. An Introduction to their Properties and Applications 1996 Butterworths/Heinemann Oxford, UK
10. M. Ashton, L. Johansson, A.S. Thornquist, and U.S. Svensson Quantitative in vivo and in vitro sex differences in artemisinin metabolism in rat Xenobiotica 29 1999 195 204
11. Bergthaller, P., 1996. Silver halide photography. In: Gregory, P. (Ed.), Chem. Technol. Print. Imaging Syst., pp. 35-75.
12. C.P. Brock, W.B. Schweizer, and J.D. Dunitz On the validity of Wallach's rule: on the density and stability of racemic crystals compared with their chiral counterparts J. Am. Chem. Soc. 113 1991 9811 9820
13. Byrn, S.R., Pfeiffer, R.R., Stowell, J.G., 1999a. Solid State Chemistry of Drugs, 2nd ed. SSCI, Lafayette, IN, p. 8.
14. Byrn, S.R., Pfeiffer, R.R., Stowell, J.G., 1999b. Solid State Chemistry of Drugs, 2nd ed. SSCI, Lafayette, IN, p. 269.
15. A.M. Buiting, Z. De Rover, and N. Van Rooijen Brucella abortus causes an accelerated repopulation of the spleen and liver of mice by macrophages after their liposome-mediated depletion J. Med. Microbiol. 42 1995 133 140
16. A.J. Carrillo-Munoz, G. Quindos, C. Tur, M.T. Ruesga, Y. Miranda, O. del Velle, P.A. Cossum, and T.L. Wallace In vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole J. Antimicrob. Chemother. 44 1999 397 401
17. T. Chandrasekaran Effect of microstructure and hardness on the grinding abrasive wear-resistance of a ball-bearing steel Wear 161 1993 105 109
18. Chaubal, M., Doty, M., Kipp, J., Papadopoulos, P., Rebbeck, C., Werling, J., Wong, J., 2003. Preparation of stable, sterile nanosuspensions for intravenous administration. In: Proceedings of the Controlled Release Society Meeting, Salt Lake City, UT, March 2003.
19. M.A. Clement, W. Pugh, and I. Parikh Tissue distribution and plasma clearance of a novel microcrystal-encapsulated flurbiprofen formulation Pharmacologist 34 1992 204
20. L. De Garavilla, N. Peltier, and E. Merisko-Liversidge Controlling the acute hemodynamic effects associated with IV administration of particulate drug dispersions in dogs Drug Develop. Res. 37 1996 86 96
21. Dearn, A.R., 1995. Atovaquone pharmaceutical compositions. European Patent EU 0/075711, August 5.
22. M. Demoy, S. Gibaud, J.P. Andreux, C. Weingarten, B. Gouritin, and P. Couvreur Splenic trapping of nanoparticles: complementary approaches for in situ studies R.H. Muller J.E. Diederichs Future Strategies for Drug Delivery with Particulate Systems 1998 Medpharm Stuttgart 17 22
23. J. Estrin Precipitation processes A.S. Myerson Handbook of Industrial Crystallization 1993 Butterworths/Heinemann Boston 131 149
24. E. Fattal, H. Alphandary, C. Weingarten, C. Vauthier, C. Dubernet, A. Andremont, and P. Couvreur Nanoparticles and liposomes for drug targetting R.H. Muller J.E. Diederichs Future Strategies for Drug Delivery with Particulate Systems 1998 Medpharm Stuttgart 1 4
25. J. Font, J. Muntasell, and E. Cesari Amorphization of organic compounds by ball milling Mater. Res. Bull. 32 1997 1691 1696
26. P. Gassmann, M. List, A. Schweitzer, and H. Sucker Hydrosols - alternatives for the parenteral application of poorly water-soluble drugs Eur. J. Pharm. Biopharm. 40 1994 64 72
27. R. Huettenrauch Molecular pharmaceutics. Part 86. Stability of activated states in solid drug forms Pharmazie 39 1984 272
28. R. Huettenrauch, and U. Moeller Molecular galenics. Part 73. Correlation between the degree of order and the wettability of solids Pharmazie 38 1983 198
29. Illingsworth, B.D., 1972. Preparation of silver halide grains. US Patent 3,655,394 (April 11).
30. B. Joost, and J. Schwedes Wear of grinding component on size reduction in stirred ball mills Chem.-Ing. Tech. 68 1996 713 717
31. 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs J. Pharm. Sci. 69 1980 755 762
32. Y. Kato, and M. Kohetsu Relationship between polymorphism and bioavailability of amobarbital in the rabbit Chem. Pharm. Bull. 29 1981 268 272
33. G.B. Kauffman The origins of heterogeneous catalysis by platinum: Johann Wolfgang Dobereiner's contributions Enantiomer 4 1999 609 619
34. M.C. Kerr, and J.S. Reed Comparative grinding kinetics and grinding energy during ball milling and attrition milling Am. Ceram. Soc. Bull. 71 1992 1809 1816
35. Kipp, J.E., Wong, J.C.T., Doty, M.J., Rebbeck, C.L., 2003. Microprecipitation method for preparing submicron suspensions. US Patent 6,607,784.
36. Kitaigorodkii Organic Chemical Crystallography 1961 Consultants Bureau New York
37. R.W. Lee, J.M. Shaw, J. McShane, and R.W. Wood Particle size reduction R. Liu Water-insoluble Drug Formulation 2000 Interpharm 487 488
38. R.W. Lee, J.M. Shaw, J. McShane, and R.W. Wood Particle size reduction R. Liu Water-insoluble Drug Formulation 2000 Interpharm 478
39. Liversidge, G.G., 1996. Drug nanocrystals for improved drug delivery. In: Proceedings of the CRS Workshop on Particulate Drug Delivery Systems, Kyoto, Japan, July 1996.
40. G.G. Liversidge, and K.C. Cundy Particle size reduction for improvement of oral bioavailability of hydrophobic drugs Int. J. Pharm. 125 1995 91 97
41. Liversidge, G.G., Cundy, K.C., Bishop, J.F., Czekal, D.A., 1992. US Patent 5,145,684 (September 8).
42. A.J. Mahajan, and D.J. Kirwan Rapid precipitation of biochemicals J. Phys. D: Appl. Phys. 26 1993 B176 B180
43. J. Mendel, D. Bugner, and A.D. Bermel Particle generation and ink particle size effects in pigmented inkjet inks. Part II J. Nanoparticle Res. 1999 421 424
44. R.H. Muller, and B.N. Bohm Nanosuspensions R.H. Muller S. Benita B. Bohm Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs 1998 Medpharm Stuttgart 152
45. Muller, R.H., Dingler, A., Schneppe, T., Gohla, S., 2000. Large-scale production of solid lipid nanoparticles (SLN) and nanosuspensions (DISSOCUBES). In: Wise, D.L. (Ed.), Handbook of Pharmaceutical Controlled Release Technology. Marcel Dekker, pp. 359-376.
46. J.W. Mullin Crystallization 4th ed. 2001 Butterworths/Heinemann Oxford, UK
47. J.W. Mullin Crystallization 4th ed. 2001 Butterworths/Heinemann Oxford, UK
48. Musliner, W.J., 1974. Precipitation of metal salts. US Patent 3,790,387 (February 5).
49. M. Otsuka, and N. Kaneniwa Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding J. Pharm. Sci. 75 1986 506 511
50. S.N. Pace, G.W. Pace, I. Parikh, and A.K. Mishra Novel injectable formulations of insoluble drugs Pharm. Technol. 23 1999 116 134
51. K. Peters, S. Leitzke, J.E. Diederichs, K. Borner, H. Hahn, R.H. Muller, and S. Ehlers Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection J. Antimicrob. Chemother. 45 2000 77 83
52. J. Philip, I.J. Holcomb, and S.A. Fusari Phenytoin K. Florey Analytical Profiles of Drug Substances vol. 13 1984 Academic Press New York 417 445
53. G. Poste, R. Kirsh, and J. Bugelski P.S. Sunkara Liposomes as a Drug Delivery System 1984 Academic Press Orlando, FL 165 230
54. R.A. Prentis, Y. Lis, and S.R. Walker Pharmaceutical innovation by the seven U.K.-owned pharmaceutical companies (1964-1984) Br. J. Clin. Pharmacol. 25 1998 387 396
55. P. Redzisqewski Predictive model for ball mill wear Can. Metall. Quart. 36 1997 87 93
56. A.J.B. Robertson The development of ideas on heterogeneous catalysis. Progress from Davy to Langmuir Platinum Met. Rev. 27 1983 31 39
57. H.G. Schroeder, B.A. Bivins, G.D. Sherman, and P.P. DeLuca Physiological effects of subvisible microspheres administered intravenously to beagle dogs J. Pharm. Sci. 67 1978 508 513
58. J.H. Senior Fate and behavior of liposomes in-vivo - a review of controlling factors CRC Crit. Rev. Ther. Drug Carrier Syst. 3 1987 123 193
59. Setler, P., 1999. Identifying new oral technologies to meet your drug delivery needs for the delivery of peptides and proteins and poorly soluble molecules. IIR Limited Drug Delivery Systems, London, March 1999.
60. E. Shefter Solubilization by solid-state manipulation S.H. Yalkowsky Techniques of Solubilization of Drugs 1981 Marcel Dekker New York 159 182
61. A.K. Singla, A. Garg, and D. Agarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
62. B. Sjostrom, B. Bergenstahl, and B. Kronberg A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. 2. Influence of the emulsifier, the solvent and the drug substance J. Pharm. Sci. 82 1993 584 589
63. B. Sjostrom, B. Kronberg, and J. Carlfors A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. 1. Influence of emulsification and surfactant concentration J. Pharm. Sci. 82 1993 579 583
64. J.D. Slack, K. Motoko, G.H. Simmons, and P.P. DeLuca Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration J. Pharm. Sci. 70 1981 660 664
65. J. Sudimack, and R.J. Lee Targeted drug delivery via the folate receptor Adv. Drug Delivery Rev. 41 2000 147 162
66. K.S. Suslick Sonochemistry Science 247 1990 1439 1445
67. M.H. Vingerhoeds, G. Storm, and D.J.A. Crommelin Immunoliposomes in vivo Immunomethods 4 1994 259 272
68. Violante, M.R., Fischer, H.W., 1989. Method for making uniformly sized particles from water-insoluble organic compounds. US Patent 4,826,689 (May 2).
69. G.W. Volcheck, and R.G. Van Dellen Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review Ann. Allergy Asthma Immunol. 80 1998 159 163
70. G.H. Ward, and R.K. Schultz Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability Pharm. Res. 12 1995 773 779
71. Westesen, K., Siekmann, B., 1998. Solid lipid particles, particles of bioactive agents, and methods for the manufacture and use thereof. US patent 5,875,976 (July 28).
72. J.W. Wheless Pediatric use of intravenous and intramuscular phenytoin: lessons learned J. Child Neurol. 13 1998 S11 S14 discussion S30-32.
73. R.D. White, J. Wong, J. Kipp, T. Barber, J. Glosson, J. Kerzee, N. Goud, J.N. Cammack, and B. Rabinow Pre-clinical evaluation of itraconazole nanosuspension for intravenous injection Toxicol. Sci. 72 2003 51
74. J.F. Willart, A. De Gusseme, S. Hemon, G. Odou, F. Danede, and M. Descamps Direct crystal to glass transformation of trehalose induced by ball milling Solid State Commun. 119 2001 501 505
75. J. Wong, J. Kipp, R. White, and T. Barber Preclinical evaluation of itraconazole nanosuspension for intravenous injection Proc. Cont. Relat. Soc. 29 2002 270
76. S.H. Yalkowsky Solubility and Solubilization in Aqueous Media 1999 American Chemical Society Washington, DC pp. 184-226